Effect of dietary glutamine on tumor glutathione levels and apoptosis-related proteins in DMBA-induced breast cancer of rats

Breast Cancer Research and Treatment

Volumn 88, Issue 3, 2004, Pages 247-256

  Todorova, Valentina K ^a   Harms, Stacy A ^a   Kaufmann, Yihong ^c   Luo, Shaoke ^a   Luo, Kevin Q ^a   Babb, Kirk ^a   Klimberg, V Suzanne ^a,b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Department of Pathology ^*  (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Bax; Bcl 2; Caspase 3; DMBA breast cancer model; Glutamine; Glutathione

Indexed keywords

CASPASE 3; DIMETHYLBENZ[A]ANTHRACENE; GLUTAMINE; GLUTATHIONE; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET; DIET SUPPLEMENTATION; FEMALE; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOCARCINOMA; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOGENS; CASPASE 3; CASPASES; DIETARY PROTEINS; DIETARY SUPPLEMENTS; FEMALE; GLUTAMINE; GLUTATHIONE; MAMMARY NEOPLASMS, EXPERIMENTAL; MODELS, ANIMAL; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY;

EID: 12344266778     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-0783-4     Document Type: Article

References (62)

1. Newsholme P, Procopio J, Lima MM, Pithon-Curi TC, Curi R: Glutamine and glutamate-their central role in cell metabolism and function. Cell Biochem Fund 21: 1-9, 2003
2. Labow BI, Souba WW: Glutamine. World J of Surg 24: 1503-1513, 2000
3. Souba WW: Intestinal glutamine metabolism and nutrition. J Nutr Biochem 4: 2-9, 1993
4. Karinch AM, Pan M, Lin CM, Strange R, Souba WW: Glutamine metabolism in sepsis and infection. J Nutr 131: 2535S-2538S, 2001
5. Oehler R, Roth E: Regulative capacity of glutamine. Curr Opin Clin Nutr Metabol Care 6: 277-282, 2003
6. Wardman P: Conjugation and oxidation of glutathione via thiyl free radicals. In: Sies H, Ketterer B (eds) Glutathione Conjugation. Mechanisms and Biological Significance, Academic Press, London, pp. 44-72, 1988
7. Reed DJ, Fariss MW: Glutathione depletion and susceptibility. Pharmacol Rev 36: 25s-33s, 1984
8. Arrigo AP: Gene expression and the thiol redox state. Free Radic Biol Med 27: 936-944, 1999
9. Rouse K, Nwokedi E, Woodliff JE, Epstein J, Klimberg VS: Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Ann Surg 221: 420-426, 1995
10. Perchellet JP, Owen MD, Posey TD, Orten DK, Schneider BA: Inhibitory effects of glutathione level-raising agents and D-alpha-tocopherol on ornithine decarboxylase induction and mouse skin tumor promotion by 12-O- tetradecanoylphorbol-13-acetate. Carcinogenesis 6: 567-557, 1985
11. Baruchel S, Wang T, Farah R, Jamali M, Batist G: In vivo selective modulation of tissue glutathione in a rat mammary carcinoma model. Biochem Pharmacol 50: 1505-1508, 1995
12. Wang T, Chen X, Schecter RL, Baruchel S, Alaoui-Lamali M, Melnychuk D, Batist G: Modulation of glutathione by a cysteine pro-drug enhances in vivo tumor response. J Pharamacol Exp Therap 276: 1169-1173, 1996
13. Oehler R, Roth E: Regulative capacity of glutamine. Curr Opin Clin Nutr Metab Care 6: 277-282, 2003
14. Schroder CP, Godwin AK, O'Dwyer PJ, Tew KD, Hamilton TC, Ozols RF: Glutathione and drug resistance. Cancer Invest 14:158-168, 1996
15. Roth E, Oehler R, Manhart N, Exner R, Wessner B, Strasser E, Spitter A: Regulative potential of glutamine-relation to glutathione metabolism. Nutrition 18: 217-221, 2002
16. Kaufmann SH, Gores GJ: Apoptosis in cancer: cause and cure. BioEssays 22: 1007-1017, 2000
17. Reed JC: Bcl-2 and the regulation of involuntary cell death. J Cell Biol 124: 1-6, 1994
18. Voehringer DW: Bcl-2 and glutathione alterations in cellular redox state that regulate apoptotic sensitivity. Free Rad Biol Med 27: 945-950, 1999
19. Hall AG: The role of glutathione in the regulation of apoptosis. Eur J Clin Invest 29: 238-245, 1999
20. Klimberg V, Nwokedi B, Hutchins L, Pappas AA, Lang NP, Broadwater JR, Read RC, Westbrook KC: Does glutamine facilitate chemotherapy while reducing its toxicity? Surg Forum 42: 16-18, 1991
21. Klimberg VS, Pappas AA, Nwokedi E, Jensen JC, Broadwater JR, Lang NP, Westbrook KC: Effect of supplemental dietary glutamine on methotrexate concentrations in tumors. Arch Surg 127: 1317-1320, 1992
22. Cao Y, Feng Z, Hoos AF, Klimberg SV: Effect of glutamine on tumor regulation of gut fractional release. Presented at the 52nd Annual Cancer Symposium of the Society of Surgical Oncology. Orlando, FL, March 4-7, 1999
23. Feng Z, Cao Y, Kornbluth J, Gray P, Fahr M, Klimberg VS: Glutamine prevents DMBA-induced breast cancer growth. Surg Forum, XLVII: 524-526, 1996
24. Farr, M, Nwokedi E, Woodliff J, Epstein J, Klimberg VS: Glutamine enhances immunoregulation of tumor growth. JPEN 18: 471-476, 1994
25. Klimberg VS, Kornbluth J, Cao Y, Dang A, Blossom S, Schaeffer RF: Glutamine suppresses PGE2 synthesis and breast cancer growth. J Surg Res 63: 293-297, 1996
26. Johnson AT, Kauffman, YC, Luo S, Todorova V, Klimberg VS: Effect of glutamine on glutathione, IGF-1 and TGF-β. J Surg: 111, 222-228, 2002
27. Geyer R, Bleisch V, Bryant J, Robbins AN, Saslaw IM, Stare FJ: Tumor production in rats injected intravenously with oil emulsions containing 9,10-dimethyl-1, 2-benzanthracene. Cancer Res 11: 474-478, 1951
28. Huggins C, Grand L, Brillantes F: Mammary CA induced by single feeding of polynuclear hydrocarbons and its suppression. Nature 189: 204-207, 1961
29. Feng Z, Kornbluth J, Cao Y, Klimberg VS: GLN prevents DMBA-induced breast cancer. Surg Forum XLVII, 110-112, 1996
30. Welsch CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45: 3415-3343, 1985
31. Fukunishi R: Studies on tumor induction in rats with 7, 12-DMBA with special references to the morphogenesis and fine structural changes in the target organs. Acta Pathol Jpn 18: 51-72, 1968
32. Costa I, Solanas M, Escrich E: Histopathologic characterization of mammary neoplastic lesions induced with 7,12 dimethylbenz(alpha)anthracene in the rat: a comparative analysis with human breast tumors. Arch Pathol Lab Med 126: 915-927, 2002
33. Huovinen R, Collan Y: Mitotic activity, apoptosis and TRPM-2 mRNA expression in DMBA-induced rat mammary carcinoma treated with anti-estrogen toremifene. Int J Cancer 55: 685-691, 1993
34. Tietze F: Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Ann Biochem 27: 502-522, 1969
35. Anderson ME: Enzymatic and chemical methods for the determination of glutathione. In: Dolphin D (ed) Glutathione, Vol. 1, John Wiley & Sons, New York, pp. 340-365, 1983
36. Griffith OW: Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106: 207-212, 1980
37. Marone M, Mozzetti S, Ritis DD, Pierelli L, Scambia G: Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol Proc Online 3: 19-25, 2001
38. Barabas E, Nagy K, Varkonyi V, Horvath A: Comparison of the quantitative competitive and semiquantitative RT-PCR methods for the determination of interferon-gamma mRNA levels in AIDS-free HIV-infected individuals. Braz J Med Biol Res, 34: 1271-1275, 2001
39. Oddiah D, Anand P, McMahon SB, Rattray M: Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder. Neuroreport 9: 1455-1458, 1998
40. Lacey J, Wilmore D: Is glutamine a conditionally essential amino acid? Nutr Rev 48: 297-309, 1990
41. Muhlbacher F, Kapadia CR, Colpoys MF, Smith RJ, Wilmore DW: Alterations in glutamine metabolism in response to operative stress and food deprivation. Surg Forum 33: 19-21, 1982
42. Savarese DM, Savy G, Vahdat L, Wischmeyer PE, Corey B: Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 29: 501-513, 2003
43. Welbourne T: Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can J Biochem 57: 233-237, 1979
44. Wolf CR, Lewis AD, Carmichael J, Adams DJ, Allan SG, Ansell DJ: The role of glutathione in determining the response of normal and tumor cells to anticancer drugs. Biochem Soc Trans 15: 728-730, 1987
45. Arrick B, Nathan C: GSH metabolism as a determinant of therapeutic efficacy: a review. Cancer Res 44: 4224-4232, 1984
46. Klimberg VS, Nwokedi E, Hutchins LH, Pappas AP, Lang NP, Broadwater JR, Read RC, Westbrook KC: Does glutamine facilitate chemotherapy while reducing its toxicity? Surg Forum 42: 16-18, 23, 1991
47. Klimberg VS, McClellan JL: Glutamine, cancer, and its therapy. Am J Surg 172: 418-424, 1996
48. Wolf CR, Hayward IP, Lawrie SS, Buckton K, McIntyre MA, Adams DJ, Lewis AD, Scott AR, Smyth JF: Cisplatinum-sensitive and resistant ovarian adenocarcinoma cell lines derived from the same patient. Proc Am Assoc Cancer Res 26: 338, 1985
49. Kaufmann Y, Todorova VK, Luo S, Harms SA, Babb KB, Hawk RM, Kim LT, Klimberg SV: Effect of glutamine on glutathione recycling in breast cancer model. Presented at Nutrition Week of A.S.P.E.N. Las Vegas, Nevada, February 9-12, 2004
50. Husson A, Quillard M, Fairand A, Chedeville A, LavoinneA: Hypoosmolarity and glutamine increased the β-actin gene transcription in isolated rat hepatocytes. FEBS Lett 394: 353-355, 1996
51. Quillard M, Husson A, Lavoinne A: Glutamine increases argininosuccinate synthetase mRNA levels in rat hepatocytes. The involvement of cell swelling. Eur J Biochem 236: 56-59, 1996
52. Bellon G, Chaqour B, Wegrowski Y, Monboisse JC, Borel J: Glutamine increases collagen gene transcription in cultured human fibroblasts. Biochim Biophys Acta 1268: 311-323, 1995
53. Warskulat U, Newsome W, Noe B, Stoll B, Haussinger D: Antiosmotic regulation of hepatic gene expression. Biol Chem.Hoppe-Seyler 377: 57-65, 1996
54. Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, Chang EB. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol 90: 2403-2410, 2001
55. Hutson RG, Kilberg MS: Cloning of rat asparagine synthetase and specificity of the amino acid-dependent control of its mRNA content. Biochem J 304: 745-750, 1994
56. Newsome WP, Warskulat U, Wettstein M, Stoll B, Gerok W, Haussinger D: Modulation of phosphoenolpyruvate carboxikinase mRNA levels by the hepatocellular hydration state. Biochem J, 304: 555-560, 1994
57. Abcouwer SF, Schwarz C, Meguid RA: Glutamine deprivation induces the expression of GADD45 and GADD 153 primarily by mRNA stabilization. J Biol Chem 274: 28645-28651, 1999
58. Quillard M, Renouf S, Husson A, Meisse D, Lavoinne A: Glutamine and regulation of gene expression in mammalian cells. Special reference to phosphoenolpyruvate carboxykinase (PEPCK). Biochemie 79: 125-128, 1997
59. Bojes HK, Datta K, Xu A, Chi P, Nunez G, Kehrer P: Bcl-xl overexpression attenuates glutathione depletion in FL5.12 cells following interleukine-3 withdrawl. Biochem J 325: 315-319, 1997
60. Ho Y, S, Lee HM, Mou TC, Lin JK: Suppression of nitric oxide-induced apoptosis by N-acetyl-L-cystein through modulation of glutathione, Bcl-2 and Bax protein levels. Mol Carcinog 19: 101-113, 1997
61. Filomeni G, Rotilio G, Ciriolo MR: Glutathione disulfide induces apoptosis in U937 cells by a redox-mediated p38 MAP kinase pathway. FASEB J 17: 64-66, 2003
62. Voehringer DW, McConkey DJ, McDonnel TJ, Brisbay S, Meyn RE: Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc Natl Acad Sci USA 95: 2956-2960, 1998